Directorate Change
Updated : 07:06
22 January 2019
Redcentric plc
("Redcentric" or the "Company")
Board Changes
Redcentric plc ("Redcentric" or "the Company") (AIM: RCN) today announces that Stephen Puckett, Independent Non-Executive Director, will retire from the Board of Directors, effective from 1 February 2019. Jonathan Kempster, Independent Non-Executive Director, will take over as Chairman of the Audit Committee.
The Company is also pleased to announce that Chris Rigg will join the Board of Directors of the Company as an Independent Non-Executive Director, also effective from 1 February 2019. Mr Rigg currently holds non-executive roles with Sportech plc and Ridge Pharma Limited. He was also previously Chief Executive Officer and Chief Financial Officer at Quantum Pharma plc and Chief Executive Officer at Northern Recruitment Group Limited. Mr Rigg is a qualified chartered accountant and will also join the audit, remuneration and nomination committees of the Board of the Company.
Chris Cole, Chairman, commented:
"On behalf of everyone at Redcentric I would like to thank Stephen for his service to the Company and wish him well in his future endeavours. I would also like to welcome Chris to Redcentric on behalf of the Board. He brings with him complementary skills and experience and we look forward to working with him.''
Additional information:
The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:
Full name: Christian Alexander Rigg
Age: 44 years
Current directorships: Fairstone Holdings Limited, Fairstone Group Limited, Fairstone Capital Investment Limited, Sportech plc, Ridge Pharma Limited
Previous directorships held in the past 5 years: Quantum Pharma Holdings Limited, Clinigen Group plc, Quantum Pharma Group Limited, Quantum Pharma 2014 Limited, Quantum Specials Limited, Quantum Specials Trustee Limited, Quantum Pharmaceutical Limited, Pharmacy Prime Limited, Protohealth Limited, Lamda Pharma Limited, UL Medicines Limited, Colonis Pharma Limited, Pern Consumer Products Limited, Protomed Limited, Healthnet Homecare Limited, Lamda (UK) Limited, Northern Recruitment Group Limited.
In addition, when Mr Rigg was CEO of Quantum Pharmaceutical Plc, NuPharm Group Limited went into administration as part of a turnaround strategy.
Enquiries:
Redcentric plc | Via Tulchan Communications |
Chris Cole, Chairman | |
Peter Brotherton, Chief Financial Officer | |
Numis Securities - NOMAD & Joint Broker | +44 (0) 20 7260 1000 |
Simon Willis / Oliver Hardy | |
finnCap Ltd - Joint Broker | +44 (0) 20 7220 0500 |
Stuart Andrews / Rhys Williams | |
Tulchan Communications | +44 (0) 207 353 4200 |
James Macey White / Matt Low |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.